share_log

Aesther Healthcare Acquisition Corp. Announces Intention To Extend Period To Consummate Business Combination

Aesther Healthcare Acquisition Corp. Announces Intention To Extend Period To Consummate Business Combination

美思醫療收購股份有限公司宣佈延長完善業務組合期的意向
Benzinga Real-time News ·  2022/12/13 09:21

New York, NY and Providence, RI, Dec. 13, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. ("Aesther") (NASDAQ:AEHA) entered into definitive merger agreement with Ocean Biomedical, Inc. Aesther announced today that its Board of Directors has approved an extension of the period of time available to Aesther to consummate a business combination by three months from December 16, 2022 to March 16, 2022 (the "Second Extension"), as permitted under Aesther's governing documents. In connection with the Second Extension, Aesther's sponsor, Aesther Healthcare Sponsor, LLC, has agreed to deposit an aggregate of $1,050,000 into Aesther's Trust account for its public stockholders, representing $0.10 per public share, by December 16, 2022, which will be in the form of a loan. Aesther's governing documents permit a total of two three-month extensions, of which this is the second.

紐約，紐約州和普羅維登斯，2022 年 12 月 13 日（GLOBE NEWSWIRE）--如先前宣布，埃斯特醫療收購股份有限公司（「Aesther」）（NASDAQ：AEHA）與海洋生物醫學公司 Aesther 今天宣布，其董事會已批准將可用的時間從 12 月 16 日的 Aesther 合併至 12 月 16 日完成三個月的業務根據美斯特的管理文件允許，2022 年至 2022 年 3 月 16 日（「第二次擴展」）。與第二次擴展有關，Aesther 的贊助商 Aesther 醫療保健贊助商有限責任公司已同意在 2022 年 12 月 16 日之前將總額 1,050,000 美元存入其公共股東的 Aesther 信託帳戶中，每股公共股份 0.10 美元，該帳戶將以貸款的形式出現。Aesther 的管理文件總共允許延期兩個月，其中第二個月。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論